Taurine is the most abundant free amino acid in heart and skeletal muscle. In the present study, the effects of hereditary taurine deficiency on muscle function were examined in taurine transporter knockout (taut−/−) mice. These mice show an almost complete depletion of heart and skeletal muscle taurine levels. Treadmill experiments demonstrated that total exercise capacity of taut−/− mice was reduced by >80% compared with wild-type controls. The decreased performance of taut−/− mice correlated with increased lactate levels in serum during exercise. Surprisingly, cardiac function of taut−/− mice as assessed by magnetic resonance imaging, echocardiography, and isolated heart studies showed a largely normal phenotype under both control and stimulated conditions. However, analysis of taut−/− skeletal muscle revealed electromyographic abnormalities. 1 H nuclear magnetic resonance spectroscopy of tissue extracts showed that in the heart of taut−/− mice the lack of taurine was compensated by the upregulation of various organic solutes. In contrast, a deficit of >10 mM in total organic osmolyte concentration was found in skeletal muscle. The present study identifies taurine transport as a crucial factor for the maintenance of skeletal muscle function and total exercise capacity, while cardiac muscle apparently can compensate for the loss of taurine.
aurine is the most abundant free amino acid in many mammalian tissues with intracellular concentrations of 20-70 mmol/kg in heart and skeletal muscle (1, 2) . The zwitterionic nature of taurine prevents its passage through lipid layers and allows the Na + -dependent taurine transport system (taut) to build up concentration gradients between cellular and extracellular spaces. Taurine is involved in cell volume homeostasis, antioxidant defense, protein T stabilization, and stress response. On the basis of its functions, taurine may protect cells in vitro against various types of injury (1) (2) (3) (4) (5) (6) (7) .
Intracellular taurine is present in high concentration and was proposed to play a role in the excitation-contraction coupling mechanism of muscle fibers (8) . In the myocardium, taurine may have antiarrhytmic properties, positive inotropic effects, and cytoprotective functions as an osmolyte or radical scavenger and during calcium-overload states. Taurine has recently been shown to protect against ischemia and heart failure (2, (9) (10) (11) . Multiple actions of taurine on ion channels and transport systems may result in modulation of intracellular calcium levels. In cat, fox, and rat, pharmacologically induced taurine deficiency leads to dilative cardiomyopathy (12) (13) (14) (15) . In clinical studies, a correlation between low plasma taurine concentrations and echocardiographic findings representative of dilated cardiomyopathy was reported (16) . Therefore, a direct link between decreased myocardial taurine levels and decreased cardiac function was proposed. To further explore the role of taurine in muscle physiology, cardiac and skeletal muscle function were examined in detail in the recently generated taurine-deficient mouse model (taut−/−) with a disrupted gene coding for the taurine transporter (17) . Taut−/− mice surprisingly show an almost normal heart function but a strongly reduced total exercise capacity most likely due to a reduced skeletal muscle function.
MATERIALS AND METHODS

Mice
The taut knockout (taut−/−) mice were generated by homologous recombination and had a mixed genetic background (C57Bl/6×129/SvJ) as described previously (17) . Wild-type (WT) mice (taut+/+) served as control animals. If not indicated otherwise, animals of both sexes were used. The mice were bred and raised at a 12-12 h light/dark cycle in the vivarium of the University of Düsseldorf and received identical feed and water ad libitum. Animal experiments were conducted according to the rules of the local ethical guidelines.
Ergometric analysis
Total exercise capacity
Three-to four-and twelve-to eighteen-month-old taut+/+ and taut−/− mice were subjected to treadmill exercise, using a Columbus Instruments Simplex II metabolic rodent treadmill, fitted with Oxymax oxygen and carbon dioxide gas analyzers (Columbus Instruments, Columbus, OH). Mice were placed in the exercise chamber, and after an adaptation period of 15-30 min, treadmill activity was initiated at a rate of 4 m/min, 14° inclination, and increased to 8 m/min 10 min later. Oxygen consumption (VO 2 ) and carbon dioxide production (VCO 2 ) were determined by flow measurement of breath air during treadmill exercise. Because of the fact that taut−/− mice show a loss of vision due to severe retinal degeneration (17) , the treadmill experiments were also carried out in darkness to measure the exercise capacity of 3-month-old WT mice, which were dark adapted 48 h before. All treadmill experiments were performed between 10 AM and 6 PM.
Lactate measurements
Treadmill activity was initiated as described above. Three-month-old mice were used. After a first indication of exhaustion (i.e., after a running time of 15±3 min), the taut−/− mouse was killed by neck fracture and venous blood was immediately taken from the right ventricle of the heart. Two minutes later, the WT mouse was prepared by the same method. In contrast to taut−/− mice, no exhaustion was seen in WT animals during this running time. This experimental procedure was repeated with three mice pairs. In control experiments, three WT and taut−/− mice were analyzed without running. The lactate levels were measured in blood serum by using the lactate oxidase-peroxidase method.
Heart perfusion setup for nuclear magnetic resonance (NMR) measurements
Preparation of hearts of 17-to 18-month-old mice and retrograde, nonrecirculating perfusion at constant pressure of 100 mmHg with modified Krebs-Henseleit buffer, gassed at 95% O 2 /5% CO 2 (carbogen), resulting in a pH of 7.4, were performed essentially as described previously (18) . Perfusion pressure, coronary flow, oxygen consumption, and left ventricular diastolic pressure (LVDP) were measured continuously, the latter via a homemade fluid-filled balloon inserted into the left ventricle. Signals were recorded using a personal computer with dedicated software (EMKA Technologies, Paris, France). The hearts were placed inside a 10 mm nuclear magnetic resonance (NMR) tube and transferred to the NMR spectrometer equipped with a 10 mm 1 H/ 31 P dual probe heated at 37°C. After hearts had stabilized, cardiac pacing (500 bpm) was initiated and continued throughout. Left ventricular enddiastolic pressure (LVEDP) was set to 5 mmHg. Thirty minutes after onset of cardiac pacing, the coronary perfusion rate was fixed to the steady flow established and was maintained constant. After the switch to constant flow, baseline data were acquired.
Ischemia/reperfusion protocol
After baseline data were recorded, hearts of each strain were subjected to 12 min of global ischemia by halting the perfusion pump and concomitantly clamping the aortic inflow, followed by 1 h of reperfusion at the initial flow rate.
Dobutamine stimulation
After acquisition of baseline values, 200 nM dobutamine were infused and hemodynamic as well as functional data were acquired.
Magnetic resonance measurements
Magnetic resonance data were recorded on a Bruker DRX 400 WB NMR spectrometer operating at frequencies of 400.1 MHz for 1 H and 161.97 MHz for 31 P measurements.
Imaging
Magnetic resonance imaging (MRI) investigations were performed using a Bruker Microimaging unit (Micro2.5) equipped with an actively shielded 40 mm gradient set (capable of 1 T/m maximum gradient strength and 110 µs rise time at 100% gradient switching) and a 30 mm birdcage resonator. Mice were slightly anaesthesized with isoflurane (1.5%). High resolution images of mice hearts were acquired using an electrocardiogram (ECG) triggered fast gradient echo cine sequence with a flip angle < 45°, echo time < 2 ms, and a repetition rate of ~4 ms. The resulting in-plane resolution was 117 × 117 µm 2 (field of view 30×30 mm 2 , 256×256 matrix). The total acquisition time per slice for one cine sequence was ~2 min. Six to eight contiguous ventricular short axis slices (slice thickness 1 mm) were acquired to cover the entire heart.
Spectroscopy
H NMR of tissue extracts
Lyophilized perchloric acid extracts were redissolved in 0.5 ml D 2 O; 512 scans were recorded from a 5-mm 1 H/ 13 C dual probe, flip angle 40°, repetition time 15 s, low power water presaturation, spectral width 5580 Hz, data size 16 K, zero filling to 32 K. Chemical shifts were referenced to (trimethylsilyl)propionic-2,2,3,3d 4 -acid (TSP) at 0 ppm.
P NMR of perfused hearts
Two-hundred and forty transients were accumulated with a 75° flip angle, repetition time 1 s taken, spectral width 5882 Hz, data size 4K, zero filling to 8K, and exponential weighting resulting in a 10 Hz line broadening. Chemical shifts were referenced to the PCr resonance at -2.52 ppm. After equilibration of the hearts within the magnet, 31 P NMR spectra were continuously recorded with a temporal resolution of 4 min. Ischemia was initiated after acquisition of four baseline spectra. NMR signals were assigned by comparison with literature data (19, 20) and confirmed by spiking the sample with pure compounds. Quantitative evaluation of the spectra was done by using the mixed lorentzian/gaussian deconvolution available under X-WinNMR 2.6 (Bruker). Relative peak areas were obtained by the implemented automatic integration routine. Integrated values were converted to concentrations as described previously (18) .
Echocardiography
Conscious 13-to 14-month-old mice were examined by echocardiography as described previously (21) . With a 15 MHz transducer connected to a Sonos 5500™ (Phillips Medical Systems; frequency fusion: 5; interrogation depth 2 cm), the heart was imaged in twodimensional (2D) mode in the parasternal long axis view. Aortic dimensions were obtained at the aortic root. Aortic flow velocity was measured with pulsed-wave Doppler after moving to the apical long axis and obtaining an image plane where the aorta was clearly visualized (equivalent to the four chamber view in humans). Cardiac output (CO) was calculated from the following equations:
where CSA is aortic cross-sectional area, SV is stroke volume, VTI is the volume time integral, and HR is heart rate. The same procedure was followed for echocardiography involving dobutamine (1.5 µg/g body weight). Images were obtained within 7 and 11 min after intraperitoneal injection, a time frame shown to represent the plateau pharmacological effect in preliminary experiments.
Nerve conduction velocity measurement
Fifteen-to eighteen-month-old mice were anaesthetized with an intramuscularly administered combination of 50 µg/10 g body weight xylazine and 1 mg/10 g body weight ketamine. The left sciatic nerve was mobilized and placed on a bipolar silver electrode for stimulation. The incision was extended to the popliteal space, and the medial head of the gastrocnemius muscle was exposed. An Ag/AgCl reference electrode was buried between the hip muscles. Square-wave pulses of 200 µs duration at a voltage supramaximal for α-axons were used to stimulate the sciatic nerve. A thin platinum wire electrode (diameter 80 µm) placed in the medial head of the gastrocnemius muscle was used to record electromyograms (EMG). Time between stimulus and onset of synchronized EMG was used to calculate conduction velocity. Thereafter, the medial gastrocnemius nerve was cut and the recording electrode was positioned in its central end. Nerve conduction velocity was calculated using time between stimulus and onset of the compound action potential.
Creatine kinase activity
Serum creatine kinase (CK) activity in nonexercised mice was measured by using standard method number 94 of International Federation of Clinical Chemistry (IFCC) in a modular instrument (Roche Diagnostics, Mannheim, Germany).
Tissue extracts and osmolyte analysis
Freshly removed tissue was immediately frozen in liquid nitrogen; the heart was perfused bloodfree before. The frozen tissues were powdered and subsequently extracted with perchoric acid (PCA), neutralized, and lyophilized.
Real time PCR
Total RNA from mouse heart and skeletal muscle samples was isolated using a total RNA extraction kit (Qiagen, Hilden, Germany) and reversely transcribed using a first-strand cDNA synthesis kit (Roche, Mannheim, Germany). The levels of gene expression were measured by real time SYBR Green PCR with the Gene Amp 5700 Sequence Detection System (Applied Biosystems) according to the instructions of the manufacturer. The primers used for PCR were 5′-AAAAATCACGAACCAGGACGG-3′ and 5′-GCCGCCCAAATTCTTTGAG-3′ for ATA1 (amino acid transport system A1) (22) , 5′-CCTTTACCCAGGCAGCGTT-3′ and 5′-CAGCGTCTGCGGTGCTATTG-3′ for ATA2 (23), 5′-CTCAACACAATCATGGACTACAACC-3′ and 5′-ACTACTCCTTTGTCC AAGACCAGG-3' for NAT1 (N system amino acid transporter 1) (24), 5′-TGCAGTGCAGCGAGAATAGC-3′ and 5′-TCCCGTTGGGAATAGTATGGC-3′ for SMIT (myoinositol transporter) (25), 5′-CTCAGAGGGAGAAGTGGTCCAG-3′ and 5′-CGGCCACAGACAGCACAA-3′ for detection of TAUT exon 1 (17) , and 5′-GCTTCCTCCTCAGACCGCTT-3′ and 5′-TTAGGTATACAAAACAAATCTAGGTCAT AACC-3′ for HPRT (hypoxanthine-guaninephosphoribosyl-transferase) as internal standard. PCR conditions were 1 cycle at 50°C for 2 min and 95°C for 10 min, and 40 cycles at 95°C for 15 s and 60°C for 1 min. The sample volume was 25 µl, respectively. After PCR, the specificity of amplified DNA was checked by recording of dissociation curve.
Materials
All compounds used in this study were either analytical grade or otherwise of the highest purity available. Dobutamine was purchased from Sigma (Deisenhofen, Germany). All other reagents were obtained from Merck (Darmstadt, Germany).
Statistical analysis
If not indicated otherwise, results are expressed as means ± SE. For multiple comparisons, ANOVA followed by the Bonferroni correction was applied. A P value of <0.05 was considered significant.
RESULTS
Ergometric analysis
For spiroergometric analysis, WT and taut−/− mice were subjected to treadmill exercise. In contrast to WT mice, which ran up to 20 m/min, taut−/− mice were not able to run faster than 8 m/min at a given angle of 14°. This observation was independent of the age of the mice. X-ray studies of the skeleton revealed no morphological abnormalities in 18-month-old taut−/− mice (data not shown), indicating that their reduced ability to exercise is not a result of severe skeletal malformation.
Experiments designed to determine total exercise capacity at lower speed showed significant differences between WT and taut−/− mice with respect to cumulative running distance. At a treadmill speed of 4 to 8 m/min, young and old WT mice ran a total distance of 2316 ± 413 m (294±52 min) and 1464 ± 99 m (188±12 min) to exhaustion, whereas age-matched taut−/− mice ran only a total distance of 443 ± 70 m (60±9 min) and 287 ± 83 m (41±10 min), respectively ( Fig. 1) . Thus, the total exercise capacity was decreased by ~80% in the taut−/− mice compared with WT controls. However, VO 2 during the exercise period (i.e., when taut−/− mice were also still running) was not significantly different between the groups ( Table 1 ). The VCO 2 /VO 2 was increased in taut−/− mice because of increased VCO 2 . As shown previously (17) , taut−/− mice show loss of vision due to severe retinal degeneration at an age beyond 1-2 months. Because of this blindness, the treadmill experiments were also carried out in darkness with dark-adapted 3-month-old mice. Similar to the experiments in light, WT mice ran a total distance >2400 m (>305 min, n=4) to exhaustion, whereas taut−/− mice ran only a total distance of 605 ± 265 m (84±33 min, n=4). Since both young and old taut−/− mice displayed a strongly reduced overall exercise capacity compared with the respective WT group, the subsequent analysis of the specific function of heart and skeletal muscle was performed in mice aged ≥12 months.
In a separate set of experiments, serum lactate concentrations were determined in exercising mice. After the first signs of exhaustion (i.e., after a running time of 15±3 min), lactate concentration in serum was significantly increased from 2.8 ± 1.0 mM in taut−/− mice without running (n=3) to 4.4 ± 0.9 mM (n=4, P<0.05) during running. In WT controls, the lactate concentration in serum was 2.8 ± 1.1 mM without running (n=3) and 2.2 ± 0.4 mM after a running time of 17 ± 3 min (n=4).
Heart function
In vivo MRI gave no evidence for any anatomical and functional alterations of the heart and showed comparable values for diastolic and systolic volumes as well as cardiac output in both groups ( Fig. 2 and Table 2 ). More detailed hemodynamic and metabolic measurements on isolated perfused hearts also revealed no significant differences between taut-deficient and WT hearts under basal conditions (Table 3) . Furthermore, dobutamine stimulation led to a similar increase in both LVDP and oxygen consumption (MVO 2 ) in hearts of both groups (Table 4 ). In taut−/− hearts, the elevated contractility was accompanied by a significantly larger drop (−36.9±9.8 mmHg; means±SD) in coronary perfusion pressure (CPP) compared with WT hearts (−16.0±8.3 mmHg, n=4, P<0.05). However, the enhanced vasodilation did not result in an increased impairment of cardiac energy state of transgenic hearts as indicated by a similar decrease in phosphocreatine (PCr) levels in both the taut−/− and the WT group during infusion of the drug (Table 4 ). Sensitivity to dobutamine stimulation was additionally confirmed by echocardiographic analysis in vivo showing a comparable increase in cardiac output in both groups (WT, 146±16%; taut−/−, 136±29%; means± SD, n=6) as measured with pulsed-wave Doppler.
Since taurine has been suggested to protect against ischemia (2, 3, 10) , an ischemia/reperfusion protocol was applied to perfused hearts in a separate series of experiments. Table 5 summarizes the data acquired during and after the ischemic insult. During 12 min of global ischemia, LVDP fell rapidly to zero and ischemic contracture developed within a few minutes resulting in a LVEDP of ~35 mmHg in all hearts. Cardiac PCr levels decreased in both groups immediately after the onset of ischemia below 31 P NMR detectibility while cellular ATP (ATP) stores were not completely depleted even after 12 min of ischemia (Table 5 ). This effect was accompanied by a large increase in inorganic phosphate (P i ) levels and a drop of intracellular pH (pH i ) to ~6 in both groups. After 60 min of reperfusion, similar values were obtained for cardiac contractile function and high energy phosphate levels in WT and taut−/− hearts. Furthermore, LVEDP data indicate comparable recovery from ischemic contracture in both groups. In summary, neither during the 12 min ischemic period itself nor during reperfusion any significant differences could be observed between the groups.
Electromyographic analysis of skeletal muscle
The decreased total exercise capacity was accompanied by a significantly lower conduction velocity in musculus gastrocnemius of taut−/− mice (11.9±1.2 m/s, n=5) than in WT controls (16.7±0.9, n=6). In contrast, nerve conduction velocity, calculated using time between stimulus in sciatic nerve and onset of the compound action potential in nervus gastrocnemius medialis, was not significantly different between taut−/− (11.3±0.5 m/s, n=4) and WT (11.0±0.9 m/s, n=3) mice.
Serum CK activity
Serum CK levels were doubled in nonexercising 6-to 12-month-old taut−/− mice (257±138 U/l, n=12) compared with WT mice (131±38 U/l, n=10, P<0.05) as well as in 12-to 18-month-old taut−/− mice (502±181 U/l, n=11) compared with WT mice (243±87 U/l, n=9, P<0.05). These pathological findings may relate to the decreased total exercise capacity of these mice found in the treadmill experiments.
Organic osmolyte content in heart and skeletal muscle 1 H NMR spectroscopy of perchloric acid extracts from taut−/− hearts showed that lack of the taurine transporter led to a nearly complete depletion of the high cardiac taurine content and induced an upregulation of the cytosolic concentration of various organic solutes (Fig. 3) . As depicted in Fig. 4 , left, the quantitatively most prominent changes were found for glutamine (+5.1±0.8 mM), alanine (+2.3±0.3 mM), acetate (+1.4±0.2 mM), and glycine (+1.3±0.3 mM) (means±SD, respectively). In line with increased intracellular glutamine and alanine concentrations, mRNA levels of the system A amino acid transport proteins ATA 1 and 2 are higher in the heart of taut−/− than of WT mice (Table 6 ). No expression of the taut exon 1 was found in either heart or skeletal muscle of taut−/− animals, whereas WT mice showed exon 1 expression in both organs. In one WT heart, TAUT mRNA-levels were unusually high (16,47 mRNA copies/HPRT mRNA copy), so that this mouse was not considered in Table 6 . Furthermore, cytosolic levels of several other spectroscopic measured organic compounds were significantly increased in taut−/− hearts, e.g. aspartate (0.41±0.16 mM in WT and 0.98±0.21 mM in taut−/−; n=4, P<0.05) or α-glycerophosphorylcholine (0.23±0.10 mM in WT and 0.59±0.17 mM in taut−/−; n=4, P<0.05). It is noteworthy that in taut−/− hearts no alteration in the cytosolic content of myo-inositol, a major osmolyte in various tissues (26, 27) , was observed (0.17±0.05 mM in WT and 0.19±0.08 mM in taut−/−), although the mRNA-levels for the myoinositol transporting system SMIT were increased by ~260% in heart of taut−/− mice ( Table 6 ). The reason for this discrepancy is unknown. Apparently, this increase in SMIT mRNA levels is not functionally relevant or the turnover of intracellular myoinositol is accelerated. The decrease in NAT1 mRNA-levels indicates that other mechanisms may play a major in the compensation of taurine loss. The sum of all spectroscopic measured compounds reveals that in the heart of taut−/− mice the taurine loss was almost fully compensated by the up-regulation of the concentration of other organic solutes (Fig. 4, left) .
Analysis of skeletal muscle extracts also showed severely decreased taurine levels in the transgenic group, but only a minor rise in the content of other osmotically active organic compounds was observed (Fig. 4, right) . The sum of the increased levels of glycine (+1.3±0.3 mM±SD), acetate (+0.9±0.2 mM), and lactate (+3.0±1.4 mM) in taut-deficient skeletal muscle did not match the decrease in taurine levels (−16 mM). In line with this, the increases in the mRNA levels of the osmolyte transporting systems SMIT, ATA1, and ATA2 in taut−/− mice compared with WT were lower in skeletal muscle than in heart (Table 6 ).
DISCUSSION
We have previously reported that disruption of the taurine transporter (taut) gene in a transgenic mouse model (taut−/−) results in severe plasma hypotaurinemia, a marked impairment of reproduction, retinal degeneration, and low levels of taurine in various tissues (17) . The present study shows that chronically lowered muscle taurine levels affect skeletal but surprisingly not cardiac muscle function. In the heart, depletion of taurine is compensated by an up-regulation of the concentration of several organic solutes, resulting in the maintenance of a normal osmolyte balance. On the other hand, in skeletal muscle taurine depletion is insufficiently compensated by organic osmolytes probably leading to functional defects, such as an impaired overall exercise capacity. The data suggest that a certain concentration of osmolytes is crucial for normal skeletal muscle function and thereby critically determines whole body performance.
Lack of the taurine transporter in taut−/− mice results in a reduction of taurine tissue levels by >98% in both skeletal and heart muscle, compared with control mice. Apparently, the defective uptake system is not compensated by taurine uptake via other transport systems such as the amino acid transport system A (17). Since taurine deficiency has been implicated as a potential cause of dilated cardiomyopathy in other animal models (12, 14, 15) , it is surprising that transgenic mice with chronically reduced cardiac taurine levels show a largely normal heart function. Acute dietary manipulation of fox and cat results in both models in strongly decreased myocardial taurine concentrations. As a consequence, animals develop cardiomyopathy characterized by systolic and diastolic dysfunction of the left ventricle. Furthermore, in rats treated with the taurine transport antagonist guanidinoethane sulfonate, observations of ventricular ultrastructure showed disordered contractile filaments and clear losses of myofibrillar bundles in association with taurine deficiency (13) . In the present study, overall cardiac contractility was unaltered as evidenced by normal cardiac function both under in vitro and in vivo conditions. Only vasodilation was enhanced in isolated perfused taut−/− hearts during dobutamine stimulation. Although this might indicate that the dobutamine stress is more challenging to taut-deficient hearts, the concentrations of energy-rich phosphates were not different between the two experimental groups. Furthermore, echocardiography demonstrated a similar sensitivity of WT and taut−/− mice to the dobutamine challenge in vivo.
In view of the previous literature on pharmacologically induced taurine depletion and the associated severe changes in cardiac function, the present finding of uncompromised cardiac contractility in the taut−/− model comes as a surprise. Similarly, the ischemia reperfusion injury observed in the taut−/− was undistinguishable from the WT control. Since taut−/− mice had to cope with taurine deficiency from their early embryonic phase to adulthood, this obviously allowed development of compensatory mechanisms described above. Thus, the cardiac phenotype of taurine depletion may critically depend on whether the effect is acutely induced, e.g., by pharmacological means or whether taurine deficiency is chronic such as in taut−/− mice. However, it could not ruled out that the observed resistance of cardiac function toward a lack of taurine transporter results from species differences. To identify these possible differences, further investigations with either a long-term treatment with the taurine transport antagonist guanidineoethane sulfonate or conditional taut−/− mice are necessary. On the basis that treatment with the taurine transport antagonist led only to a 65% decrease in taurine levels in rats (13) whereas taut−/− mice show a reduction of 98-99% (17), a conditional taut−/− mouse model is preferable in which the taurine content can be reduced in young as well as only in adult mice.
In contrast to the heart, skeletal muscle of taut−/− mice shows pronounced abnormalities: a reduced action potential speed as shown by electromyography and a deficit of >10 mM in total organic osmolyte concentration. In addition, morphological abnormalities in taut−/− mice cannot be ruled out: in a blind study, toluidine blue-stained semithin sections of gastrocnemius muscles of four 14-to 16-month-old male taut−/− mice and three male WTs between 9.5-17 months of age were analyzed using a bright field light microscope at a numerical aperture of 0.65 (U. Warskulat, H.-G. Hartwig, and D. Häussinger, unpublished data). The number of irregularly appearing muscle fibrils (local swelling of adjacent sarcomers and regions with nonsynchronized arrangement of adjacent sarcomers) was considerably higher in taut−/− mice. In consequence, in this blind study it was possible to identify two different types of muscle morphology. These correlated well with the genetic background of the samples investigated. In contrast to these findings but in line with the functional data, no differences in morphology were found in a blinded study on semithin sections of the left cardiac ventricle (n=3 female and n=4 male 10-to 16-month-old taut−/− mice vs. n=3 male WT animals between 10-17 months of age). However, at present it cannot be excluded that the observed changes of morphology may be due to agedependent structural defects of skeletal muscle found in inbred mice strains (28) . Detailed morphological studies are required to settle these issues. However, it is most likely that changes in taut−/− skeletal muscle account for the decreased overall exercise capacity observed. Furthermore, the increased lactate release during exercise and the elevated serum CK levels in taut−/− mice give additional evidence that the reduced performance of these mice is due to a disturbance of normal skeletal muscle function. The impaired integrity of taut−/− skeletal muscle may be directly linked to the loss of taurine, since taurine has been shown to exert its beneficial effects on muscle function via several mechanisms.
First, the large amount of intracellular taurine present in mammalian skeletal muscle plays a role in the excitation-contraction coupling mechanism (8, 29) . This action is independent of any effect involving muscle Cl -channels, but it is likely mediated by the taurine transporter present in sarcoplasmic reticulum. Taurine may therefore increase the magnitude of depolarizationinduced force responses by augmenting sarcoplasmatic reticulum Ca 2+ accumulation and release.
Second, taurine is released by contracting skeletal muscles, e.g., gastrocnemius muscles, but its actual role remains unspecified (30) . This taurine release is primarily found in fast-twitch dominant fibers. Changes in the plasma taurine content during endurance exercise are partly related to an osmoregulatory process (31) . Taurine supplementation or taurine depletion had measurable cytoprotective actions to attenuate exercise-induced injury (32) . Taurine shows a voltage-dependent dualistic action on Ca
2+
-regulated K + -channels, being an inhibitor of the channel at positive membrane potentials and an activator at negative membrane potentials (33, 34) . During ischemia and hypoxia, skeletal and heart muscles undergo several changes, e.g., the activation of ATP-regulated K + -channels and loss of intracellular taurine. The depletion of taurine during ischemia would contribute to the early activation of ATP-regulated K + -channels and salvage the intracellular ATP content. On the other hand, impairment of taut−/− skeletal muscle function may be caused by the reduced osmolyte capacity. This disturbed osmolyte balance will result in maladaptation to cell volume changes induced by osmotic, hormonal, or oxidative stress or contraction (36, 37) . Impaired cell volume homeostasis will increase the probability of cell dysfunction evoked by cell swelling or shrinkage in taut−/− skeletal muscle. This presumption would also explain the observed differences between heart and skeletal muscle in taut−/− mice: the maintained cardiac function may relate to compensated cardiac osmolyte balance mediated by the up-regulation of several organic solutes. Organic osmolytes and cell volume homeostasis are known to play an important role in apoptosis (38) (39) (40) . In nucleated cells for example, taurine is released after induction of apoptosis and high extracellular taurine levels will blunt apoptosis during hyperosmotic shock (38) . The phenotype of taut−/− mice younger than 1 month is already characterized by a severe retinal degeneration leading to blindness presumably due to apoptosis of photoreceptor cells (17) . On the other hand, taurine transporter deficiency led to an increase in erythrocyte resistance toward apoptosis (39) . In contrast to the retina (17) , no significant increase in apoptotic rate was found in skeletal muscle of taut−/− mice indicating that their dysfunction may be not mediated by apoptotic mechanisms (U. Warskulat and D. Häussinger, unpublished data). The reason why heart but not skeletal muscle can compensate for the loss of taurine is presently not known. The previously described reduced reproduction of taut−/− mice (17) could have been due to a selection process in which only animals with a compensated cardiac osmolyte balance survived. Disturbance of osmolyte homeostasis in skeletal muscle is obviously not lethal during embryonic development and results in the observed phenotype.
In conclusion, the present study identifies the taurine transporter and a certain osmolyte concentration as important factors for the maintenance of exercise capacity as well as for normal skeletal muscle function. It furthermore demonstrates that the heart can compensate for the loss of taurine. Transversal sections (short axis orientation) were shown in A and C and coronal sections in B and D. After mice had been anesthetized with 1.5% isofluran, electrocardiogram, and respiration-triggered fast gradient echo cine sequences were applied for imaging during the whole cardiac cycle (field of view: 30×30 mm 2 , slice thickness: 1 mm, matrix size: 256 × 256, repetition rate: 4 ms, echo time: 1.8 ms, flip angle: 45°). Resulting in-plane resolution was 117 × 117 µm 2 . In vivo MR imaging gave no evidence for any anatomical alterations of the heart and showed comparable values for diastolic and systolic volumes as well as cardiac output in both groups (see also Hearts and skeletal muscles from 15-month-old mice were isolated and analyzed as indicated in Methods. Ace, acetate; Ala, alanine; Cho, cholines (including choline, phosphocholine, and glycerophosphocholine); Gln, glutamine; Glu, glutamate; Gly, glycine; Lac, lactate; Tau, taurine. Data are means ± SD (n=3, *P<0.05 vs. WT group).
